Companies / PDS Biotechnology Corp

PDS Biotechnology Corp

Nasdaq: PDSBCIK 1472091PRINCETON, NJ

Financials

Revenue—
Net income$-34.50M
Total debt$15.00M
Cash$5.60M
Diluted EPS$-0.74
Shares outstanding55.8M

Ownership

55.8M shares outstanding · as of May 7, 2026
14.6%Institutions
Ownership
Institutions14.64%8,171,907
Public float85.36%47,643,746

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 11

View all →
Insider% of sharesShares
Ali-Jackson KamilDirector
——
Bedu-Addo FrankCEOPresident/CEO · Director
——
Boesgaard LarsFormerChief Financial Officer
——
Brawley Otis WDirector
——
Brown Spencer D.FormerSenior VP, General Counsel
——
Conn GregoryFormerChief Scientific Officer
——
Freitag Gregory GeneDirector
——
Glover Stephen C.Director
——
Iliev IlianDirector
——
Shepard Kirk V.Chief Medical Officer
——

Institutional holders 46

View all →
HolderValue% of shares
Armistice Capital, LLC$2.18M5.08%
Vanguard Group Inc$1.50M3.50%
BlackRock, Inc.$535.4K1.09%
Geode Capital Management, LLC$399.5K1.18%
UBS Group AG$193.8K0.45%
Blair William & CO/IL$192.4K0.45%
Commonwealth Equity Services, LLC$151.5K0.35%
Squarepoint Ops LLC$148.2K0.34%
Inspirion Wealth Advisors, LLC$138.9K0.32%
Renaissance Technologies LLC$133.6K0.40%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 12, 2026Iliev Ilian
Director
GrantEmployee Stock Option (Right to Buy)—+55K
54,876
0.10% of shares
low
Jan 12, 2026Bedu-Addo Frank
CEO
GrantEmployee Stock Option (Right to Buy)—+549K
548,782
0.98% of shares
low
Jan 12, 2026Conn Gregory
Executive
GrantEmployee Stock Option (Right to Buy)—+150K
150,000
0.27% of shares
low
Jan 12, 2026Toutain Stephan
Executive
GrantEmployee Stock Option (Right to Buy)—+300K
300,000
0.54% of shares
low
Jan 12, 2026Ali-Jackson Kamil
Director
GrantEmployee Stock Option (Right to Buy)—+55K
54,876
0.10% of shares
low
Jan 12, 2026Freitag Gregory Gene
Director
GrantEmployee Stock Option (Right to Buy)—+55K
54,876
0.10% of shares
low
Jan 12, 2026Shepard Kirk V.
Executive
GrantEmployee Stock Option (Right to Buy)—+300K
300,000
0.54% of shares
low
Jan 12, 2026Boesgaard Lars
Executive
GrantEmployee Stock Option (Right to Buy)—+300K
300,000
0.54% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
PDSBCommon StockEquity70465T107BBG004NCDK82